Press Release: Akelos : Akelos Receives Australian Patent Allowance on Lead Compound, AKE-1018
Akelos -1018 for Chronic Neuropathic Pain NEW YORK, NY, UNITED STATES, April 16, 2025 /EINPresswire.com/ -- Akelos Receives Australian Patent Allowance on Lead Compound, AKE-1018 Patent Covers Inventions Licensed from Weill Cornell Medicine AKE- ...
Read full article »
Akelos is a New York-based biopharmaceutical company that researches and develops non-narcotic drugs for the treatment of neuropathic conditions.
Read more